Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly
CERS Cerus Corporation monthly Stock Chart
CERS [NASD]
Cerus Corporation
Healthcare | Biotechnology | USA
statements
Index- P/E- EPS (ttm)-0.51 Insider Own2.20% Shs Outstand160.74M Perf Week14.68%
Market Cap835.04M Forward P/E- EPS next Y-0.32 Insider Trans-5.51% Shs Float158.79M Perf Month9.14%
Income-71.20M PEG- EPS next Q-0.10 Inst Own65.20% Short Float6.13% Perf Quarter12.93%
Sales93.80M P/S8.90 EPS this Y-16.50% Inst Trans0.27% Short Ratio4.75 Perf Half Y15.70%
Book/sh0.40 P/B12.99 EPS next Y22.00% ROA-41.90% Target Price8.00 Perf Year-20.57%
Cash/sh0.53 P/C9.74 EPS next 5Y- ROE-112.60% 52W Range2.71 - 6.64 Perf YTD23.10%
Dividend- P/FCF- EPS past 5Y0.30% ROI-65.50% 52W High-21.76% Beta1.09
Dividend %- Quick Ratio2.20 Sales past 5Y20.80% Gross Margin64.40% 52W Low91.70% ATR0.43
Employees254 Current Ratio2.50 Sales Q/Q31.20% Oper. Margin-70.60% RSI (14)63.28 Volatility6.55% 11.39%
OptionableYes Debt/Eq0.78 EPS Q/Q0.60% Profit Margin-76.00% Rel Volume0.57 Prev Close5.01
ShortableYes LT Debt/Eq0.69 EarningsFeb 20 AMC Payout- Avg Volume2.05M Price5.20
Recom1.40 SMA2026.12% SMA5013.03% SMA2009.58% Volume1,176,425 Change3.69%
Feb-26-20Initiated BTIG Research Buy $7
Nov-13-19Upgrade BTIG Research Neutral → Buy $7
Aug-28-19Initiated Stifel Buy
Aug-23-19Resumed Stephens Overweight
Jan-05-18Resumed Cantor Fitzgerald Overweight
Dec-08-17Resumed BTIG Research Neutral
Jul-07-16Resumed Cantor Fitzgerald Buy $9
Dec-17-15Downgrade Wedbush Outperform → Neutral
May-02-14Reiterated MLV & Co Buy $8.50 → $6
Apr-24-13Reiterated Cantor Fitzgerald Buy $5.50 → $6
Mar-15-13Reiterated MLV & Co Buy $7.50 → $8.50
Apr-17-12Initiated Cantor Fitzgerald Buy $5.50
Feb-29-12Upgrade Robert W. Baird Neutral → Outperform $3 → $6
Nov-10-11Reiterated MLV & Co Buy $4 → $5
Jun-03-11Initiated Wedbush Outperform $4
Mar-04-11Downgrade Robert W. Baird Outperform → Neutral $4 → $3
Mar-09-10Upgrade Robert W. Baird Neutral → Outperform $3 → $5
Aug-26-09Upgrade Avondale Mkt Perform → Mkt Outperform $2 → $5
Jul-28-09Downgrade Robert W. Baird Outperform → Neutral $3
May-04-09Downgrade JMP Securities Mkt Perform → Mkt Underperform
Apr-07-20 08:40AM  Introducing Cerus (NASDAQ:CERS), The Stock That Dropped 26% In The Last Year Simply Wall St.
Apr-06-20 08:30AM  Cerus Corporation Provides Update on COVID-19 Related Activities Business Wire +6.35%
Apr-02-20 08:30AM  University Hospital Basel, Switzerland Transfuses First Two COVID-19 Patients With INTERCEPT Treated Coronavirus Convalescent Plasma Business Wire
08:30AM  Cerus Corporation Announces the Inclusion of Pathogen Reduction Technology in the ISBT Working Party Recommendations for the Preparation of COVID-19 Convalescent Plasma Business Wire
Mar-26-20 08:30AM  Cerus Forms Group to Research Optimal Production of COVID-19 Convalescent Plasma Business Wire +7.92%
Mar-02-20 04:56PM  Edited Transcript of CERS earnings conference call or presentation 20-Feb-20 9:30pm GMT Thomson Reuters StreetEvents
04:10PM  Cerus Corporation Announces Strategic Organizational Changes Business Wire
Feb-25-20 03:25PM  18 Medical Stocks To Watch Amid The Coronavirus Outbreak Benzinga
08:30AM  Cerus Corporation to Participate in Upcoming Investor Conferences Business Wire
Feb-22-20 07:58AM  Cerus Corporation Just Reported, And Analysts Assigned A US$8.25 Price Target Simply Wall St.
Feb-20-20 04:01PM  Cerus Corporation Announces Record Fourth Quarter and Full Year 2019 Financial Results Business Wire
Feb-18-20 08:30AM  U.S. Department of Defense Awards Funding for Study to Evaluate the Use of INTERCEPT Plasma in Traumatic Burn Resuscitation Business Wire
Feb-12-20 08:30AM  Cerus Corporation to Release Fourth Quarter and Full Year 2019 Financial Results on February 20, 2020 Business Wire
Feb-06-20 06:06AM  Trade Alert: The Independent Director Of Cerus Corporation (NASDAQ:CERS), Franklin Witney, Has Just Spent US$100k Buying Shares Simply Wall St.
Jan-31-20 04:01PM  Cerus Corporation Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares Business Wire
Jan-29-20 09:00AM  Cerus Corporation Announces Pricing of Upsized Public Offering of Common Stock Business Wire
Jan-28-20 04:01PM  Cerus Corporation Announces Public Offering of Common Stock Business Wire -7.57%
Jan-23-20 03:14PM  The latest coronavirus stock screamers: Inovio Pharmaceuticals, Co-Diagnostics MarketWatch
01:02PM  13 Coronavirus-Related Stocks To Watch Amid Wuhan Outbreak Benzinga
08:30AM  Coronavirus Inactivation Reported in Recent INTERCEPT Blood System Publication in Transfusion Medicine Business Wire
Jan-21-20 08:30AM  French Hemovigilance Report Highlights Safety and Effectiveness of INTERCEPT Platelets During First Full Year of 100% Production and Routine Use Business Wire +10.07%
Jan-13-20 08:30AM  Cerus Corporation Announces Preliminary Fourth Quarter and Full Year 2019 Product Revenue Business Wire -7.91%
Dec-30-19 02:08PM  Is Cerus (NASDAQ:CERS) Using Debt Sensibly? Simply Wall St.
Dec-16-19 04:38PM  Cerus Corporation (CERS): Are Hedge Funds Right About This Stock? Insider Monkey
Dec-12-19 08:30AM  Cerus Corporation Announces New Five-Year INTERCEPT Blood System Agreement With Swiss Transfusion SRC Business Wire
Nov-30-19 09:01AM  Edited Transcript of CERS earnings conference call or presentation 30-Oct-19 8:30pm GMT Thomson Reuters StreetEvents
Nov-13-19 08:30AM  Cerus Corporation to Present at the Stifel 2019 Healthcare Conference Business Wire
Nov-12-19 06:45AM  How Should Investors React To Cerus Corporation's (NASDAQ:CERS) CEO Pay? Simply Wall St.
Nov-08-19 08:30AM  Cerus Corporation to Present at the Stephens Nashville Investment Conference Business Wire
Nov-01-19 09:34AM  Were Hedge Funds Right About Cashing Out Of Cerus Corporation (CERS)? Insider Monkey +6.67%
07:38AM  The Daily Biotech Pulse: Amgen Takes 20.5% Stake In BeiGene, Paratek's Mixed Clinical Readout, CareDx Slips On Guidance Benzinga
Oct-30-19 06:45PM  Cerus (CERS) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:01PM  Cerus Corporation Announces Third Quarter 2019 Results Business Wire
Oct-23-19 10:34AM  Will Cerus (CERS) Report Negative Earnings Next Week? What You Should Know Zacks
Oct-21-19 08:30AM  Cerus Corporation to Release Third Quarter 2019 Results and to Discuss Recent FDA Guidance for Bacterial Safety of Platelets on October 30, 2019 Business Wire
Oct-18-19 08:30AM  Cerus Corporation Announces Schedule of Presentations at the 2019 AABB Annual Meeting Business Wire
Oct-13-19 09:36AM  How Much Are Cerus Corporation (NASDAQ:CERS) Insiders Taking Off The Table? Simply Wall St.
Sep-30-19 12:00PM  Cerus Corporation Applauds the Publication of the Final Guidance Document on Bacterial Safety Standards for Platelet Collection and Transfusion Business Wire +6.07%
Sep-27-19 08:30AM  Cerus Corporation to Present at the 2019 Cantor Global Healthcare Conference Business Wire
Sep-13-19 07:05AM  Did You Miss Cerus's (NASDAQ:CERS) 32% Share Price Gain? Simply Wall St.
Sep-03-19 06:02PM  Edited Transcript of CERS earnings conference call or presentation 1-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
Aug-28-19 08:30AM  Cerus Corporation to Participate in Upcoming Investor Conferences Business Wire
Aug-14-19 09:44AM  What Kind Of Shareholder Appears On The Cerus Corporation's (NASDAQ:CERS) Shareholder Register? Simply Wall St.
Aug-01-19 09:24PM  Cerus Corporation (CERS) Q2 2019 Earnings Call Transcript Motley Fool
06:35PM  Cerus (CERS) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:01PM  Cerus Corporation Announces Record Second Quarter 2019 Results Business Wire
Jul-25-19 10:34AM  Analysts Estimate Cerus (CERS) to Report a Decline in Earnings: What to Look Out for Zacks
Jul-22-19 08:30AM  Cerus Corporation to Release Second Quarter 2019 Results on August 1, 2019 Business Wire
Jul-08-19 11:54AM  Cerus Corporation (NASDAQ:CERS): Time For A Financial Health Check Simply Wall St.
Jul-05-19 04:39PM  Heres What Hedge Funds Think About Cerus Corporation (CERS) Insider Monkey
Jun-24-19 06:00PM  Cerus Corporation Announces Presentations Highlighting INTERCEPT Blood System at the 29th Regional Congress of the ISBT Business Wire
Jun-13-19 08:01AM  Edited Transcript of CERS earnings conference call or presentation 7-May-19 8:30pm GMT Thomson Reuters StreetEvents
Jun-04-19 02:16PM  How Cerus Corporation (NASDAQ:CERS) Can Impact Your Portfolio Volatility Simply Wall St.
Jun-03-19 08:30AM  Cerus Corporation Announces New Corporate Brand and Global Headquarters Business Wire
May-14-19 08:44AM  Cerus INTERCEPT Blood System Provides Alternative to Year-Round Babesia Testing in Latest FDA Guidance Document Business Wire
May-07-19 08:23PM  Cerus Corporation (CERS) Q1 2019 Earnings Call Transcript Motley Fool
07:25PM  Cerus (CERS) Reports Q1 Loss, Tops Revenue Estimates Zacks
06:18PM  Cerus: 1Q Earnings Snapshot Associated Press
04:05PM  Cerus Corporation Announces Record First Quarter 2019 Results Business Wire
10:53AM  Heres What Hedge Funds Think About Cerus Corporation (CERS) Insider Monkey
Apr-30-19 10:32AM  Analysts Estimate Cerus (CERS) to Report a Decline in Earnings: What to Look Out for Zacks
Apr-25-19 08:30AM  Cerus Corporation to Release First Quarter 2019 Results on May 7, 2019 Business Wire
Apr-24-19 11:48AM  Cerus Corporation (NASDAQ:CERS) Insiders Have Been Selling Simply Wall St.
Apr-01-19 04:05PM  Cerus Corporation Strengthens Balance Sheet with an Expandable Debt Facility of up to $90 Million Business Wire
Mar-05-19 04:15PM  Cerus Corporation Announces Appointment of Jami Nachtsheim to Board of Directors Business Wire
Feb-28-19 10:31PM  Edited Transcript of CERS earnings conference call or presentation 26-Feb-19 9:30pm GMT Thomson Reuters StreetEvents
Feb-26-19 11:02PM  Cerus Corporation (CERS) Q4 2018 Earnings Conference Call Transcript Motley Fool
04:02PM  Cerus Corporation Announces Record Fourth Quarter and Full Year 2018 Results Business Wire
Feb-22-19 08:30AM  Cerus to Participate In Upcoming Investor Conferences Business Wire
Feb-21-19 11:20AM  How Much Of Cerus Corporation (NASDAQ:CERS) Do Institutions Own? Simply Wall St.
Feb-14-19 07:20AM  Consolidated Research: 2019 Summary Expectations for Varonis, Dolby Laboratories, Alder BioPharmaceuticals, Retail Properties of America, Cerus, and Motorcar Parts of America Fundamental Analysis, Key Performance Indications GlobeNewswire
Feb-13-19 08:30AM  Cerus to Release Fourth Quarter and Full Year 2018 Results on February 26, 2019 Business Wire
Jan-16-19 11:00AM  How Should Investors React To Cerus Corporations (NASDAQ:CERS) CEO Pay? Simply Wall St.
Jan-07-19 08:30AM  Cerus Announces Preliminary Fourth Quarter and Full Year 2018 Product Revenue Business Wire
Jan-04-19 08:30AM  William Moore Appointed as Cerus Corporations Senior Vice President of Manufacturing Operations and Supply Chain Business Wire
Dec-19-18 08:30AM  Cerus Announces First Patient Enrolled in the Phase 3 ReCePI Study Business Wire
Dec-18-18 08:30AM  Cerus Completes CE Mark Submission for INTERCEPT Red Blood Cells Business Wire
02:14AM  Do Hedge Funds Love Cerus Corporation (CERS)? Insider Monkey
Dec-17-18 10:39AM  What Investors Should Know About Cerus Corporations (NASDAQ:CERS) Financial Strength Simply Wall St.
Dec-10-18 08:30AM  American Red Cross Receives Biologics License Application Approval For INTERCEPT Platelets Business Wire
Dec-04-18 05:00PM  Cerus Supports FDAs Continuing Efforts to Enhance the Safety of the U.S. Platelet Supply Business Wire
Nov-15-18 10:48AM  Does Cerus Corporation (NASDAQ:CERS) Have A Particularly Volatile Share Price? Simply Wall St.
Nov-12-18 07:20AM  Report: Developing Opportunities within Lexicon Pharmaceuticals, Cray, RCI Hospitality, Sanmina, Diamond Offshore Drilling, and Cerus Future Expectations, Projections Moving into 2018 GlobeNewswire -8.03%
Nov-09-18 08:30AM  Cerus to Present at the 2018 Canaccord Genuity Medical Technologies & Diagnostics Forum Business Wire
Nov-08-18 07:19PM  Edited Transcript of CERS earnings conference call or presentation 1-Nov-18 8:15pm GMT Thomson Reuters StreetEvents
Nov-02-18 08:30AM  Cerus to Present at the 2018 Stephens NY Investment Conference Business Wire -5.91%
Nov-01-18 05:25PM  Cerus: 3Q Earnings Snapshot Associated Press
04:01PM  Cerus Corporation Reports Third Quarter 2018 Results Business Wire
Oct-31-18 08:30AM  Cerus Receives FDA Breakthrough Device Designation for Pathogen-Reduced Cryoprecipitate Business Wire +6.52%
Oct-23-18 08:30AM  Cerus to Release Third Quarter 2018 Results on November 1, 2018 Business Wire
Oct-18-18 08:10AM  Detailed Research: Economic Perspectives on Cerus, AdvanSix, Spark Therapeutics, Imperva, Central Garden & Pet, and Francesca's What Drives Growth in Today's Competitive Landscape GlobeNewswire
Oct-16-18 03:01PM  Here's Why Cerus Corporation Stock Popped Today Motley Fool +15.44%
08:30AM  Cerus to Provide Update to Development Programs and Outline Growth Strategy at 2018 Institutional Investor Meeting Business Wire
Oct-12-18 08:30AM  Cerus Announces Schedule of Presentations at the 2018 AABB Annual Meeting Business Wire
Oct-11-18 08:30AM  Dr. Laurence Corash Recognized With the Prestigious Dale A. Smith Memorial Award Business Wire
Oct-10-18 11:28AM  Cerus Corporations (NASDAQ:CERS) Most Important Factor To Consider Simply Wall St. -5.03%
Oct-09-18 04:05PM  Cerus Appoints Eric Bjerkholt to Board of Directors Business Wire
Oct-02-18 08:30AM  Cerus to Host Institutional Investor Meeting Business Wire
Sep-26-18 08:30AM  Cerus to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference Business Wire
Sep-06-18 04:15PM  Cerus Appoints Timothy L. Moore to Board of Directors Business Wire
Cerus Corporation, a biomedical products company, focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma that is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; and INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company has a collaboration with the National Trauma Institute to supply Intercept plasma for use in the plasma resuscitation without lung injury (PROpOLIs) clinical study. Cerus Corporation was founded in 1991 and is headquartered in Concord, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Moore CarolSVP Reg. & QualityMar 17Sale3.5926,68495,92174,445Mar 24 09:29 PM
Menard ChrystalChief Legal OfficerMar 17Sale3.5926,53595,38555,285Mar 24 09:26 PM
Jayaraman Vivek KChief Commercial OfficerMar 17Sale3.5923,50084,475111,371Mar 24 09:24 PM
Greenman William MarinerPresident and CEOMar 17Sale3.59108,011388,267699,590Mar 24 09:19 PM
Green Kevin DennisChief Financial OfficerMar 17Sale3.5926,62595,70983,612Mar 24 09:15 PM
CORASH LAURENCE MChief Scientific OfficerMar 17Sale3.5917,50062,9071,802,758Mar 24 09:12 PM
Benjamin Richard JChief Medical OfficerMar 17Sale3.5926,57095,5114,478Mar 24 09:09 PM
MOORE TIMOTHY L.DirectorFeb 11Buy4.753,61417,1657,911Feb 13 05:54 PM
ANDERSON TIMOTHY BDirectorJan 29Buy4.159,63940,002187,498Feb 03 08:20 PM
MOORE TIMOTHY L.DirectorJan 29Buy4.153,61414,9987,911Feb 03 08:21 PM
NACHTSHEIM JAMI KDirectorJan 29Buy4.152,41010,0022,410Feb 03 08:18 PM
Witney FrankDirectorJan 29Buy4.1524,09699,99860,305Feb 03 08:17 PM
BJERKHOLT ERICDirectorJan 29Buy4.1520,00083,00024,282Feb 03 08:16 PM
Swisher Daniel N JRDirectorJan 29Buy4.151,0004,15045,910Feb 06 05:32 PM
SCHULZE GAILDirectorDec 04Option Exercise1.8015,00027,00040,986Dec 06 07:00 PM
SCHULZE GAILDirectorDec 04Sale4.1915,00062,85025,986Dec 06 07:00 PM
CORASH LAURENCE MChief Scientific OfficerNov 01Option Exercise3.7513,00048,7501,751,925Nov 04 05:56 PM
CORASH LAURENCE MChief Scientific OfficerOct 25Option Exercise3.7512,00045,0001,738,925Oct 28 07:55 PM
CORASH LAURENCE MChief Scientific OfficerOct 09Option Exercise3.7530,000112,5001,726,925Oct 15 04:47 PM
CORASH LAURENCE MChief Scientific OfficerOct 02Option Exercise3.7530,000112,5001,696,925Oct 04 07:10 PM
Greenman William MarinerPresident and CEOSep 24Option Exercise2.1540,00086,000678,485Sep 24 08:42 PM
Moore CarolSVP Reg. & QualitySep 16Option Exercise2.1530,00064,50097,740Sep 18 06:47 PM
Moore CarolSVP Reg. & QualitySep 16Sale5.3330,000159,82867,740Sep 18 06:47 PM
ANDERSON TIMOTHY BDirectorAug 19Option Exercise2.6219,00549,793184,472Aug 20 07:00 PM
ANDERSON TIMOTHY BDirectorAug 19Sale5.569,13150,739176,541Aug 20 07:00 PM
ANDERSON TIMOTHY BDirectorAug 16Option Exercise2.6219,00049,780177,649Aug 20 07:00 PM
ANDERSON TIMOTHY BDirectorAug 16Sale5.259,66450,736167,985Aug 20 07:00 PM
Benjamin Richard JChief Medical OfficerAug 07Sale5.0116,44482,3240Aug 09 05:12 PM
Greenman William MarinerPresident and CEOJun 04Buy4.6010,00046,000638,485Jun 04 05:09 PM
Greenman William MarinerPresident and CEOApr 22Option Exercise1.06100106628,485Apr 22 05:27 PM
Green Kevin DennisChief Financial OfficerApr 10Option Exercise2.152,7865,99082,059Apr 10 05:50 PM
Green Kevin DennisChief Financial OfficerApr 10Sale6.512,78618,13879,273Apr 10 05:50 PM
open in yahoo | open in reuters | open in google